Welcome to Facts, not fantasy. This is a "learning node" of the internet where we try to clear up some misconceptions and lies that are going around about vaccines and evolution. Click on the main item of interest (Vaccines or Evolution) and you should find a list of "points" that you are free to use (or research). All we ask is that you link back to this page if you use anything from it.
Thank you for visiting.

Facts, not Fantasy

Amazon Contextual Product Ads

Tuesday, July 26, 2011

Influenza Virus Vaccine for the 2011 - 2012 Season

Cumulative 2011/2012 Season Lot Release Status (Updated 7/21/2011)
Flu vaccine lots that have been released by FDA and are available for distribution by the manufacturers. For information on flu vaccine distribution schedules, please contact the manufacturers directly.

Vaccine & Manufacturer

Total number of Lots
Released by FDA

AFLURIA
CSL Limited

0

Fluarix
GlaxoSmithKline Biologicals

11

FluLaval
ID Biomedical Corp. of Quebec

15

FluMist
MedImmune, LLC

5

Fluvirin
Novartis Vaccines and Diagnostics Limited

3

Fluzone
Sanofi Pasteur, Inc.

27

FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Bethesda, Maryland, on February 25, 2011, to select the influenza viruses for the composition of the influenza vaccine for the 2011-2012 U.S. influenza season. During this meeting, the advisory committee reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics of recent influenza isolates, serological responses to 2010-2011 vaccines, and the availability of candidate strains and reagents.

The committee recommended that vaccines to be used in the 2011-2012 influenza season in the U.S. contain the following:

This year’s vaccine for the United States includes the same viruses that were used for the 2010-2011 influenza season and the influenza vaccine composition is identical to that recommended by the World Health Organization on February 17, 2011, for the Northern Hemisphere's 2011-2012 influenza season.